Quiz Answers: Treatments for presbyopia coming soon

Publication
Article
Optometry Times JournalNovember digital edition 2020
Volume 12
Issue 11

This quiz accompanies THIS article from our November issue

Click HERE to return to the quiz

1. What is the prevalence of presbyopia in the U.S.?

a. 5,000,000

b. 10,500,000

c. 50,000,000

d. 110,000,000

2. Miotics have few side effects.

a. True

b. False

3. Which of these devices uses pinhole optics (PHO)?

a. Revision Raindrop

b. Karama Inlay

c. FOV Tears

d. Allergan Presbysol

e. B and D

4. Which of these is not a pharmaco-refractive product?

a. Oraisis CSF-1

b. Presbyopia Therapies PRX-100

c. Allergan AGN

d. Eyenovia Micro-dose

e. All are pharmaco-refractive

5. What is the most common ingredient in current pharmaceutical drops for presbyopia being tested?

a. Dexamethasone

b. Pilocarpine

c. Bromfenac

d. Tropicamide

e. None of the above

6. Which of these is a device?

a. Oraisis CSF-1

b. Presbyopia Therapies PRX-100

c. Allergan AGN

d. Eyenovia Micro-dose

e. FOV Tears

7. Which is an active ingredient in PRX-100?

a. Pilocarpine

b. Tropicamide

c. Oxymetazoline

d. Polyethylene glycol

e. Diclofenac

This quiz accompanies THIS article from our November issue

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Carolyn Majcher, OD, FAAO, details a Collaborative Care Symposium 2025 presentation given with Prethy Rao, MD.
Mitch Ibach, OD, FAAO, details the importance of identifying the best candidates and practicing comanagement for refractive surgery.
Susana Marcos, PhD, outlines a presentation she gave at ARVO 2025 on a unique utilization of optical coherence tomography.
Karl Stonecipher ASCRS 2025
AnnMarie Hipsley, DPT, PhD, at ASCRS 2025
Neda Shamie, MD; Selina McGee, OD, FAAO, Dipl ABO; and Jacob Lang, OD, FAAO; provided their insights during CIME 2025 on May 4.
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Dr Jacob Lang at the 2025 Controversies in Modern Eye Care meeting
At ASCRS 2025, Alex Hacopian, MD, shares information from his presentation on next-gen presbyopia-correcting intraocular lenses.
© 2025 MJH Life Sciences

All rights reserved.